GGHC
Gilder Gagnon Howe & Co’s Eli Lilly LLY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.65M | Sell |
7,250
-12,198
| -63% | -$9.51M | 0.06% | 137 |
|
2025
Q1 | $16.1M | Sell |
19,448
-153,470
| -89% | -$127M | 0.21% | 91 |
|
2024
Q4 | $133M | Sell |
172,918
-44,044
| -20% | -$34M | 1.44% | 17 |
|
2024
Q3 | $192M | Sell |
216,962
-34,785
| -14% | -$30.8M | 2.3% | 9 |
|
2024
Q2 | $228M | Sell |
251,747
-10,439
| -4% | -$9.45M | 2.86% | 6 |
|
2024
Q1 | $204M | Sell |
262,186
-32,385
| -11% | -$25.2M | 2.55% | 7 |
|
2023
Q4 | $172M | Sell |
294,571
-9,656
| -3% | -$5.63M | 2.36% | 9 |
|
2023
Q3 | $163M | Sell |
304,227
-13,290
| -4% | -$7.14M | 2.49% | 8 |
|
2023
Q2 | $149M | Buy |
317,517
+21,450
| +7% | +$10.1M | 2.04% | 11 |
|
2023
Q1 | $102M | Buy |
296,067
+69,310
| +31% | +$23.8M | 1.68% | 18 |
|
2022
Q4 | $83M | Buy |
226,757
+51,615
| +29% | +$18.9M | 1.55% | 14 |
|
2022
Q3 | $56.6M | Buy |
175,142
+172,139
| +5,732% | +$55.7M | 0.99% | 25 |
|
2022
Q2 | $974K | Buy |
+3,003
| New | +$974K | 0.02% | 199 |
|
2016
Q1 | – | Sell |
-5,167
| Closed | -$435K | – | 250 |
|
2015
Q4 | $435K | Sell |
5,167
-17
| -0.3% | -$1.43K | 0.01% | 194 |
|
2015
Q3 | $434K | Buy |
+5,184
| New | +$434K | 0.01% | 211 |
|